Get startedLog in
    Picture of Pharmicell Co logo

    005690 — Pharmicell Co Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Pharmicell Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line5,2429,51310,8853,5786,331
    Depreciation
    Amortisation
    Non-Cash Items2,743-14487.51,7551,457
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-776-16,327-5,2433,640-7,353
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities8,978-5,2227,91411,8143,498
    Capital Expenditures-559-4,304-18,949-6,016-4,278
    Purchase of Fixed Assets
    Other Investing Cash Flow Items-3,046-5,041-1,58411,932-2,522
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Sale of Intangible Assets
    Change in Net Intangibles
    Other Investing Cash Flow
    Cash from Investing Activities-3,605-9,345-20,5325,916-6,800
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-17818,512-270-18,713-3,215
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash4,2345,272-11,853-635-5,463